Hodgkin Lymphoma

Cancer Epidemiology and Prevention

Volumn , Issue , 2009, Pages

  Mueller, Nancy E ^a   Grufferman, Seymour ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer epidemiology; Cancer prevention; Cancer risk; Hl; Hodgkin lymphoma; Lymph nodes

Indexed keywords

EID: 84920422368     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195149616.003.0045     Document Type: Chapter

References (378)

1. Abramson JH. 1974. Childhood experience and Hodgkin's disease in adults: An interpretation of incidence data. Br J Med Sci 10:1365-1370.
2. Abramson JH, Pridan H, Sacks MI, Avitzour M, Peritz E. 1978. A case-control study of Hodgkin's disease in Israel. J Natl Cancer Inst 61:307-314.
3. Acheson ED, Pippard EC, Winter PD. 1984. Mortality of English furniture makers. Scand J Work Environ Health 10:211-217.
4. Alderson MR, Nayak R. 1971. A study of space-time clustering in Hodgkin's disease in the Manchester region. Br J Prev Soc Med 25:168-173.
5. Alderson MR, Nayak R. 1972. Epidemiology of Hodgkin's disease. J Chron Dis 25:253-259.
6. Alexander FE. 1990. Clustering and Hodgkin's disease. Br J Cancer 62:708-711.
7. Alexander FE, Daniel CP, Armstrong AA, et al. 1995. Case clustering, Epstein-Barr virus Reed-Sternberg cell status and herpes virus serology in Hodgkin's disease: Results of a case-control study. Eur J Cancer 31A: 1479-1486.
8. Alexander FE, Jarrett RF, Cartwright RA, et al. 2001. Epstein-Barr virus and HLA-DPB 1-*301 in young adult Hodgkin's disease: Evidence for inherited susceptibility to Epstein-Barr virus in cases that are EBV+ve. Cancer Epidemiol Biomarkers Prev 10:705-709.
9. Alexander FE, Jarrett RF, Lawrence D, et al. 2000. Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: Prior infection by EBV and other agents. Br J Cancer 82:1117-1121.
10. ve HD in young adults. Int J Cancer 107:298-302.
11. Alexander FE, McKinney PA, Williams J, Ricketts TJ, Cartwright RA. 1991a. Epidemiological evidence for the two-disease hypothesis in Hodgkin's disease. Int J Epidemiol 20:354-361.
12. Alexander FE, Ricketts TJ, McKinney PA, Cartwright RA. 1991b. Community lifestyle characteristics and incidence of Hodgkin's disease in young people. Int J Cancer 48:10-14.
13. Alexander FE, Williams J, McKinney PA, Ricketts TJ, Cartwright RA. 1989. A specialist leukaemia/lymphoma registry in the UK. Part 2. Clustering of Hodgkin's disease. Br J Cancer 60:948-952.
14. Ambinder RF, Browning PJ, Lorenzana I, et al. 1993. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood 81:462-467.
15. Ambinder RF, Mann R. 1994. Epstein-Barr-encoded RNA in situ hybridization. Hum Pathol 25:602-605.
16. Ambinder RF, Weiss LM. 1999. Association of Epstein-Barr virus with Hodgkin's disease. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM, eds. Hodgkin's Disease. Philadelphia: Lippincott Williams and Wilkins, pp. 79-98.
17. American Cancer Society. 2005. Cancer Facts and Figures. Atlanta: American Cancer Society.
18. Amlot PL, Green LA. 1978. Atopy and immunoglobulin E concentrations in Hodgkin's disease and other lymphomas. Br Med J 1:327-329.
19. Amlot PL, Slaney J. 1981. Hypergammaglobulinaemia E in Hodgkin's disease and its relationship to atopy or a familial predisposition to atopy. Int Arch Allergy Appl Immunol 64:138-145.
20. Anagnostopoulos I, Hansmann M-L, Franssila K, et al. 2000. European Task Force on Lymphoma project on lymphoctye predominance Hodgkin disease: Histologic and immunohistologic analysis of submitted cases reveals two types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 96:1889-1899.
21. Aozasa K, Ueda T, Tamai M, Tsujimura T. 1986. Hodgkin's disease in Osaka, Japan (1964-1985). Eur J Cancer Clin Oncol 22:1117-1119.
22. Armstrong AA, Shield L, Gallagher A, Jarrett RF. 1998. Lack of involvement of known oncogenic DNA viruses in Epstein-Barr virus-negative Hodgkin's disease. Br J Cancer 77:1045-1047.
23. Aterman K. 1986. Thomas Hodgkin (1798-1866). Am J Dermatopathol 8:157-167.
24. Axdorph U, Porwit-MacDonald A, Sjöberg J, et al. 1999. Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors, and blood lymphocyte function. Br J Cancer 81:1182-1187.
25. Baker KS, Defor TE, Burns LJ, Ramsey NKC, Neglia JP, Robison LL. 2003. New malignancies after blood or marrow stem-cell transplantation in children and adults: Incidence and risk factors. J Clin Oncol 21:1352-1358.
26. Ball TM, Castro-Rodriguez JA, Griffith KA, Holberg CJ, Martinez FD, Wright AL. 2000. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med 343:538-543.
27. Bargou RC, Emmerich F, Krappmann D, et al. 1997. Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 100:2961-2969.
28. Barnes PJ, Karin M. 1997. Nuclear factor-κB-A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071.
29. Barton DE, David FN, Fix E. 1966. Tests for space-time interaction and a power function. Proceedings of the 5th Berkeley Symposium on Mathematical Statistics and Probability. Berkeley, University of California Press.
30. Beck A, Pazolt D, Grabenbauer GG, et al. 2001. Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: Comparison with Hodgkin's disease. J Pathol 194:145-151.
31. Begg C, Zhang Z. 1994. Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev 3:173-175.
32. Benenson AS, ed. 1995. Control of Communicable Diseases Manual. 16th ed. Washington, DC: American Public Health Association, pp. 535-536.
33. Berger C, Day P, Meier G, Zingg W, Bossart W, Nadal D. 2001. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease. J Med Virol 64:505-512.
34. Bernard SM, Cartwright RA, Bird CC, Richards ID, Lauder I, Roberts BE. 1984. Aetiologic factors in lymphoid malignancies: A case-control epidemiological study. Leuk Res 8:681-689.
35. Bernard SM, Cartwright RA, Darwin CM, et al. 1987. Hodgkin's disease: Case control epidemiological study in Yorkshire. Br J Cancer 55:85-90.
36. Bibeau F, Brousset P, Knecht H, et al. 1994. Epstein-Barr virus replication in Hodgkin's disease. Bull Cancer 81:114-118.
37. Bierman PJ, Vose JM, Langnas AN, et al. 1996. Hodgkin's disease following solid organ transplantation. Ann Oncol 7:265-270.
38. Bjerrum OW, Hasselbalch HC, Drivsholm A, Nissen NI. 1986. Non-Hodgkin malignant lymphomas and Hodgkin's disease in first-degree relatives. Evidence for a mutual genetic predisposition? Scand J Haematol 36:398-401.
39. Boice JD Jr., Land CE, Preston DL. 1996. Ionizing radiation. In: Schottenfeld D, Fraumeni JF Jr., eds. Cancer Epidemiology and Prevention. 2nd ed. New York: Oxford University Press, pp. 319-354.
40. Boiocchi M, Dolcetti R, de Re V, Gloghini A, Carbone A. 1993. Demonstration of a unique Epstein-Barr virus-positive cellular clone in metachronous multiple localizations of Hodgkin's disease. Am J Pathol 142:33-38.
41. Bonelli L, Vitale V, Bistolfi F, Landucci M, Bruzzi P. 1990. Hodgkin's disease in adults: Association with social factors and age at tonsillectomy. A case-control study. Int J Cancer 45:423-427.
42. Boyle MJ, Vasak E, Tschuchnigg M, et al. 1993. Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: Association between B-type EBV and immunocompromise. Blood 81:468-474.
43. Briggs NC, Hall HI, Brann EA, Moriarty CJ, Levine RS. 2002. Cigarette smoking and risk of Hodgkin's disease: A population-based case-control study. Am J Epidemiol 156:1011-1020.
44. Brocksmith D, Angel CA, Pringle JH, Lauder J. 1991. Epstein-Barr viral DNA in Hodgkin's disease: Amplification and detection using the polymerase chain reaction. J Pathol 165:11-15.
45. Brousset P, Chittal S, Schlaifer D, et al. 1991. Detection of Epstein-Barr virus messenger RNA in Reed-Sternberg cells of Hodgkin's disease by in situ hybridization with biotinylated probes on specially modified acetone methyl benzoate xylene (ModAmex) sections. Blood 77:1781-1786.
46. Brousset P, Knecht H, Rubin B, et al. 1993. Demonstration of Epstein-Barr virus replication in Reed-Sternberg cells of Hodgkin's disease. Blood 82:872-876.
47. Brousset P, Schlaifer D, Meggetto F, et al. 1994. Persistence of the same viral strain in early and late relapse of Epstein-Barr virus-associated Hodgkin's disease. Blood 84:2447-2451.
48. Bryden H, MacKenzie J, Andrew L, et al. 1997. Determination of HLA-A*02 antigen status in Hodgkin's disease and analysis of an HLA-A*02 restricted epitope of the Epstein-Barr virus LMP-2 protein. Int J Cancer 72:614-618.
49. Callahan BC, Coe R, Place HM. 1994. Hodgkin disease of the spine presenting as alcohol-related pain. A case report and review of the literature. J Bone Joint Surg Am 76:119-121.
50. Carbone A, Gloghini A, Zanette I, Canal B, Rizzo A, Volpe R. 1993. Co-expression of Epstein-Barr virus latent membrane protein and vimentin in "aggressive" histological subtypes of Hodgkin's disease. Virchows Arch A Pathol Anat Histopathol 422:39-45.
51. Carter CD, Brown TM Jr, Herbert JT, Heath CW Jr. 1977. Cancer incidence following infectious mononucleosis. Am J Epidemiol 105:30-36.
52. Cartwright RA, Gurney KA, Moorman AV. 2002. Sex ratios and the risks of haematological malignancies. Br J Haematol 118:1071-1077.
53. Chakravarti A, Halloran SL, Bale SJ, Tucker MA. 1986. Etiological heterogeneity in Hodgkin's disease: HLA linked and unlinked determinants of susceptibility independent of histological concordance. Genet Epidemiol 3:407-415.
54. Chang ET, Montgomery SM, Richiardi L, Ehlin A, Ekbom A, Lambe M. 2004. Number of siblings and risk of Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 13:1235-1243.
55. Chang ET, Zheng T, Lennette ET, et al. 2004c. Heterogeneity of risk factors and antibody profiles in Epstein-Barr virus genome-positive and genomenegative Hodgkin's lymphoma. J Infect Dis 189:2271-2281.
56. Chang ET, Zheng T, Weir E, Borowitz M, Mann R, Mueller N. 2004b. Aspirin and the risk of Hodgkin's lymphoma in a population-based case-control study. J Natl Cancer Inst 96:305-315.
57. Chang ET, Zheng T, Weir E, et al. 2004a. Childhood social environment and Hodgkin's lymphoma in a population-based case-control study. Cancer Epidemiol Biomarkers Prev 13:1361-1370.
58. Chang KL, Albujar PF, Chen Y-Y, Johnson RM, Weiss LM. 1993. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru. Blood 81:496-501.
59. Chang Y, Cesarman E, Pessin MS, et al. 1994. Identification of herpesviruslike DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869.
60. Chatenoud L, Gallus S, Altieri A, et al. 2005. Number of siblings and risk of Hodgkin's and other lymphoid neoplasmas. Cancer Epidemliol Biomarkers Prev 14:552. Letter.
61. Chatenoud L, Tavani A, LaVecchia C, et al. 1998. Whole grain intake and cancer risk. Int J Cancer 77:24-28.
62. Chen YT, Zheng T, Chou MC, Boyle P, Holford TR. 1997. The increase of Hodgkin's disease incidence among young adults. Experience in Connecticut, 1935-1992. Cancer 79:2209-2218.
63. Christiansen SC. 2000. Day care, siblings, and asthma-please, sneeze on my child. N Engl J Med 343:574-575.
64. Clemmesen J. 1981. To the epidemiology of Hodgkin's lymphogranulomatosis. J Belge Radiol 3:263-271.
65. Coates PJ, Slavin G, D'Ardenne AJ. 1991. Persistence of Epstein-Barr virus in Reed-Sternberg cells throughout the course of Hodgkin's disease. J Pathol 164:291-297.
66. Cohen BM, Smetana HE, Miller RW. 1964. Hodgkin's disease: Long survival in a study of 388 World War II army cases. Cancer 17:856.
67. Cole P, Mack T, Rothman K, Henderson B, Newell G. 1973. Tonsillectomy and Hodgkin's disease. N Engl J Med 288:634-635.
68. Connelly RR, Christine BW. 1974. A cohort study of cancer following infectious mononucleosis. Cancer Res 34:1172-1178.
69. Cope JU, Askling J, Gridley G, et al. 2003. Appendectomy during childhood and adolescence and the subsequent risk of cancer in Sweden. Pediatrics 111:1343-1350.
70. Correa P, O'Conor GT. 1971. Epidemiologic patterns of Hodgkin's disease. Int J Cancer 8:192-201.
71. Cozen W, Gill PS, Ingles SA, et al. 2004. IL-6 levels and genotype are associated with risk of young adult Hodgkin's lymphoma. Blood 103:3216-3221.
72. Cozen W, Katz J, Mack T. 1992. Risk patterns of Hodgkin's disease in Los Angeles vary by cell type. Cancer Epidemiol Biomarkers Prev 1:261-268.
73. Cozen W, Masood R, Mack T, Gill PS, Ablashi DV. 1998. Seroprevalence of Kaposi's sarcoma-associated herpes virus antibody in young adult Hodgkin's disease. Blood 91:724-728.
74. Cunningham WF. 1917. The status of diphtheroids with special reference to Hodgkin's disease. Am J Med Sci 153:406-412.
75. Cusano MM, Young JL Jr. 1986. Forty-five years of Cancer Incidence in Connecticut: 1935-1979. NIH publication no. 86-2652. Bethesda, MD: National Cancer Institute, U.S. Department of Health and Human Service.
76. Cuzick J, Edwards R. 1990. Spatial clustering for inhomogeneous populations. JR Stat Soc B 52:73-104.
77. Dal Maso L, Franceschi S. 2003. Epidemiology of non-Hodgkin's lymphomas and other haemolymphopoietic neoplasms in people with AIDS. Lancet Oncol 4:110-119.
78. Davis MK, Savitz DA, Graubard BI. 1988. Infant feeding and childhood cancer. Lancet 2:365-368.
79. Davis S. 1986. Case aggregation in young adult Hodgkin's disease. Etiologic evidence from a population experience. Cancer 51:1602-1612.
80. de Sanjose S, Zock J-P, Cavalle N, et al. 2004. Occupational exposure to immunologically active agents and risk for lymphoma. Cancer Epidemiol Biomarkers Prev 13:1814-1818.
81. De Vita VT, Bonadonna G. 1999. The history of the chemotherapy of Hodgkin's disease. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM, eds. Hodgkin's Disease. Philadelphia: Lippincott Williams and Wilkins, pp. 9-22.
82. Deacon EM, Pallesen G, Niedobitek G, et al. 1993. Epstein-Barr virus and Hodgkin's disease: Transcriptional analysis of virus latency in the malignant cells. J Exp Med 177:339-349.
83. Delsol G, Brousset P, Chittal S, Rigal-Huguet F. 1992. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated Bam HI-W probes in Hodgkin's disease. Am J Pathol 140:247-253.
84. Demers PA, Boffetta P. 1998. Cancer risk from occupational exposure to wood dust, a pooled analysis of an epidemiological study. IARC Technical Report No. 30. Lyon, France: International Agency for Research on Cancer.
85. Devesa SS, Grauman DJ, Blot WJ, Pennello GA, Hoover RN, Fraumeni JF Jr. 1999. Atlas of Cancer Mortality in the United States: 1950-1994. NIH publication no. 99-4564. Bethesda, MD: National Cancer Institute.
86. Di Biagio E, Sanchez-Borges M, Desenne JJ, Suarez-Chacon R, Somoza R, Acquatella G. 1996. Eosinophilia in Hodgkin's disease: A role for interleukin 5. Int Arch Allergy Immunol 110:244-251.
87. Diepstra A, Niens M, Vellenga E, et al. 2005. Association with HLA class I in Epstein-Barr-virus positive and with HLA class III in Epstein-Barr-virusnegative Hodgkin's lymphoma. Lancet 365:2216-2224.
88. Dockerty JD, Sharples KJ, Borman B. 1999. An assessment of spatial clustering of leukemias and lymphomas among young people in New Zealand. J Epidemiol Community Health 53:154-158.
89. Dores GM, Metayer C, Curtis RE, et al. 2002. Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years. J Clin Oncol 20:3484-3494.
90. Dukers DF, Jaspars LH, Vos W, et al. 2000. Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease. J Pathol 190:143-149.
91. Ederer F, Myers MH, Mantel N. 1964. A statistical problem in space and time: Do leukemia cases come in clusters? Biometrics 20:626.
92. Egan KM, Sosman JA, Blot WJ. 2005. Sunlight and reduced risk of cancer: Is the real story vitamin D? J Natl Cancer Inst 97:161-163.
93. Enblad G, Sandvej K, Lennette E, et al. 1997. Lack of correlation between EBV serology and presence of EBV in the Hodgkin and Reed-Sternberg cells of patients with Hodgkin's disease. Int J Cancer 72:394-397.
94. Enblad G, Sandvej K, Sundström C, Pallesen G, Glimelius B. 1999. Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish population. Acta Oncolgica 38:425-429.
95. Evans AS. 1971. The spectrum of infections with Epstein-Barr virus: A hypothesis. J Infect Dis 124:330-337.
96. Evans AS, Comstock GW. 1981. Presence of elevated antibody titers to Epstein-Barr virus before Hodgkin's disease. Lancet 1:1183-1186.
97. Evans AS, Gutensohn (Mueller) N. 1984. A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin's disease and their siblings. Int J Cancer 34:149-157.
98. Evans AS, Mueller N. 1990. Viruses and cancer: Causal associations. Ann Epidemiol 1:71-92.
99. Fellbaum C, Hansmann M-L, Niedermeyer H, et al. 1992. Influence of Epstein-Barr virus genomes on patient survival in Hodgkin's disease. Am J Clin Pathol 98:319-323.
100. Filipovich AH, Mathur A, Kamat D, Shapiro RS. 1992. Primary immunodeficiencies: Genetic risk factors for lymphoma. Cancer Res 52 (Suppl):5465-5467s.
101. Flavell KJ, Biddulph JP, Powell JE, et al. 2001. South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's disease. Br J Cancer 85:350-356.
102. Flavell KJ, Biddulph JP, Constandinou CM, et al. 2000. Variation in the frequency of Epstein-Barr virus-associated Hodgkin's disease with age. Leukemia 14:748-753.
103. Flavell K, Constandinou C, Lowe D, et al. 1999. Effect of material deprivation on Epstein-Barr infection in Hodgkin's disease in the West Midlands. Br J Cancer 80:604-608.
104. Fonte R, Grigis L, Grigis P, Franco G. 1982. Chemicals and Hodgkin's disease. Lancet 2:50.
105. Foss HD, Herbst H, Oelmann E, et al. 1993. Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases. Br J Haematol 84:627-635.
106. Franceschi S, Bidoli E, La Vecchia C. 1994. Pregnancy and Hodgkin's disease. Int J Cancer 58:465-466.
107. Fraumeni JF Jr., Li FP. 1969. Hodgkin's disease in childhood: An epidemiologic study. J Natl Cancer Inst 42:681-691.
108. Frisan T, Sjoberg J, Dolcetti R, et al. 1995. Local suppression of Epstein-Barr virus (EBV)-specifically cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 86:1493-1501.
109. Frisch M, Biggar RJ, Engels EA, Goedert JJ for the AIDS-Cancer Match Registry Study Group. 2001. Association of cancer with AIDS-related immunosuppression in adults. JAMA 285:1736-1745.
110. Gallagher A, Armstrong AA, MacKenzie J, et al. 1999. Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease. Int J Cancer 84:442-448.
111. Gallagher A, Perry J, Shield L, Freeland J, MacKenzie J, Jarrett RF. 2002. Viruses and Hodgkin's disease: No evidence of novel herpes viruses in non-EBV-associated lesions. Int J Cancer 101:259-264.
112. Garnier JL, Lebranchu Y, Dantal J, et al. 1996. Hodgkin's disease after transplantation. Transplantation 61:71-76.
113. Gately MK, Renzetti LM, Magram J, et al. 1998. The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses. Ann Rev Immunol 16:495-521.
114. George WK, Miller M, George WD. 1965. Hodgkin's disease in roommates. J Am Coll Health Assoc 13:399-402.
115. Gilman EA, McNally RJQ, Cartwright RA. 1999. Space-time clustering of Hodgkin's disease in parts of the UK, 1984-1993. Leuk Lymphoma 36:85-100.
116. Glaser SL. 1987. Regional variation in Hodgkin's disease incidence by histologic subtype in the US. Cancer 60:2841-2847.
117. Glaser SL. 1990. Hodgkin's disease in black populations: A review of the epidemiologic literature. Semin Oncol 17:643-659.
118. Glaser SL. 1991. Black-white differences in Hodgkin's disease incidence in the United States by age, sex, histology subtype and time. Int J Epidemiology 20:68-74.
119. Glaser SL. 1994. Reproductive factors in Hodgkin's disease in women: A review. Am J Epidemiol 139:237-246.
120. Glaser SL, Clarke CA, Nugent RA, Stearns CB, Dorfman RF. 2002. Social class and risk of Hodgkin's disease in young-adult women in 1988-94. Int J Cancer 98:110-117.
121. Glaser SL, Clarke CA, Stearns CB, Dorfman RF. 2001. Age variation in Hodgkin's disease risk factors in older women: Evidence from a population-based case-control study. Leuk Lymphoma 42:997-1004.
122. Glaser SL, Hsu JL. 2002. Hodgkin's disease in Asians: Incidence patterns and risk factors in population-based data. Leukemia Res 26:261-269.
123. Glaser SL, Lin RJ, Stewart SL, et al. 1997. Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data. Int J Cancer 70:375-382.
124. Glaser SL, Swartz WG. 1990. Time trends in Hodgkin's disease incidence: The role of diagnostic accuracy. Cancer 66:2196-2204.
125. Gledhill S, Gallagher A, Jones DB, et al. 1991. Viral involvement in Hodgkin's disease: Detection of clonal type A Epstein-Barr virus genomes in tumour samples. Br J Cancer 64:227-232.
126. Goedert JJ. 2000. The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol 27:390-401.
127. Grässer FA, Murray PG, Kremmer E, et al. 1994. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): Immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood 84:3792-3798.
128. Green JA, Dawson AA, Valerio D. 1979. Hodgkin's disease and infectious mononucleosis. Scand J Haematol 23:313-314.
129. Green MS. 1992. The male predominance in the incidence of infectious diseases in children: A postulated explanation for disparities in the literature. Int J Epidemiol 21:381-386.
130. Greenberg RS, Grufferman S, Cole P. 1983. An evaluation of space-time clustering in Hodgkin's disease. J Chronic Dis 36:257-262.
131. Greene MH, Brinton LA, Fraumeni JH Jr., d'Amico R. 1978. Familial and sporadic Hodgkin's disease associated with occupational wood exposure. Lancet 2:626-627.
132. Greenwald P, Rose JS, Daitch PB. 1979. Acquaintance networks among leukemia and lymphoma patients. Am J Epidemiol 110:162-177.
133. Grilli M, Pizzi M, Memo M, Spano P. 1996. Neuroprotection by aspirin and sodium salicylate through blockade of NFκB activation. Science 274:1383-1385.
134. Grufferman S. 1977. Clustering and aggregation of exposures in Hodgkin's disease. Cancer 39(4 Suppl):1829-1833.
135. Grufferman S, Cole P, Smith PG, Lukes RJ. 1977. Hodgkin's disease in siblings. N Engl J Med 296:248-250.
136. Grufferman S. 1982. Hodgkin's disease. In: Schottenfeld D, Fraumeni JF, Jr., eds. Cancer Epidemiology and Prevention. Philadelphia, WB Saunders Co., pp. 739-753.
137. Grufferman S. 1995. Is Hodgkin's disease infectious? Eur J Cancer 31A:1388-1389.
138. Grufferman S, Ambinder RF, Shugart YY, Brecher ML, Gilchrist GS. 1998a. Increased cancer risk in families of children with Hodgkin's disease [abstract]. Am J Epidemiol 147:S8.
139. Grufferman S, Barton JW 3rd, Eby NL. 1987. Increased sex concordance of sibling pairs with Behcet's disease, Hodgkin's disease, multiple sclerosis and sarcoidosis. Am J Epidemiol 126:365-369.
140. Grufferman S, Cole P, Levitan TR. 1979. Evidence against transmission of Hodgkin's disease in high schools. N Engl J Med 300:1006-1011.
141. Grufferman S, Davis MK, Ambinder RF, Shugart YY, Gilchrist GS, Brecher ML. 1998b. A protective effect of breast feeding on risk of Hodgkin's disease in childhood. Paediatr Perinat Epidemiol 12:A13.
142. Grufferman S, Delzell E. 1984. Epidemiology of Hodgkin's disease. Epidemiol Rev 6:76-106.
143. Grufferman S, Duong T, Cole P. 1976. Occupation and Hodgkin's disease. J Natl Cancer Inst 57:1193-1195.
144. Gulley ML, Eagen PA, Quintanilla-Martinez L, et al. 1994. Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: Association with mixed cellularity subtype and Hispanic American ethnicity. Blood 83:1595-1602.
145. Gulley ML, Glaser SL, Craig FE, et al. 2002. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma. Am J Clin Pathol 117:259-267.
146. Gutensohn (Mueller) N. 1982. Social class and age at diagnosis of Hodgkin's disease: New epidemiologic evidence on the two-disease hypothesis. Cancer Treat Rep 66:689-695.
147. Gutensohn (Mueller) N, Cole P. 1977. Epidemiology of Hodgkin's disease in the young. Int J Cancer 19:595-604.
148. Gutensohn (Mueller) N, Cole P. 1980. Epidemiology of Hodgkin's disease. Semin Oncol 7:92-102.
149. Gutensohn (Mueller) N, Cole P. 1981. Childhood social environment and Hodgkin's disease. N Engl J Med 304:135-140.
150. Gutensohn (Mueller) N, Li FP, Johnson RE, Cole P. 1975. Hodgkin's disease, tonsillectomy and family size. N Engl J Med 292:22-25.
151. Gutensohn (Mueller) N, Shapiro D. 1982. Social class risk factors among children with Hodgkin's disease. Int J Cancer 30:433-435.
152. Haim N, Cohen Y, Robinson E. 1982. Malignant lymphoma in first-degree blood relatives. Cancer 49:2197-2200.
153. Hakansson N, Floderus B, Gustavsson P, Feychting M, Hallin N. 2001. Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiol 12:552-557.
154. Halnan KE. 1988. Failure to substantiate two cases of alleged occupational radiation carcinogenesis. Lancet i:639.
155. Hamilton-Dutoit SJ, Pallesen G. 1992. A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphoma. Am J Pathol 140:1315-1325.
156. Harris NL, Jaffe ES, Stein H, et al. 1994. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392.
157. Hartge P, Devesa SS, Fraumeni JF Jr. 1994. Hodgkin's disease and non-Hodgkin's lymphoma. Cancer Surv 19/20:423-453.
158. Harty LC, Lin AY, Goldstein AM, et al. 2002. HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease. Blood 99:690-693.
159. Heath CW, Rosenstock JG, Lobdell G. 1971. An epidemic of Hodgkin's disease? Lancet ii:426-427.
160. Hellman S. 1999. A brief consideration of Thomas Hodgkin and his times. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM, eds. Hodgkin's Disease. Philadelphia: Lippincott Williams and Wilkins, pp. 3-7.
161. Henderson BE, Dworsky R, Pike MC, et al. 1979. Risk factors for modular sclerosis and other types of Hodgkin's disease. Cancer Res 39:4507-4511.
162. Henle W, Henle G. 1973. Epstein-Barr virus-related serology in Hodgkin's disease. Natl Cancer Inst Monog 36:79-84.
163. Henle W, Henle G, Andersson J, et al. 1987. Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc Natl Acad Sci USA 84:570-574.
164. Herbst H, Dallenbach F, Hummel M, et al. 1991. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA 88:4766-4770.
165. Herbst H, Foss HD, Samol J, et al. 1996. Frequent expression of interleukin10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease. Blood 87:2918-2929.
166. Herbst H, Niedobitek G. 1993. Epstein-Barr virus and Hodgkin's disease. Int J Clin Lab Res 23:13-16.
167. Herbst H, Niedobitek G, Kneba M, et al. 1990. High incidence of Epstein-Barr virus genomes in Hodgkin's disease. Am J Pathol 137:13-18.
168. Herbst H, Samol J, Foss HD, Raff T, Niedobitek G. 1997. Modulations of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus. J Pathol 182:299-306.
169. Herbst H, Steinbrecher E, Niedobitek G, et al. 1992. Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease. Blood 80:484-491.
170. Herbst H, Tippelmann G, Aragnostopoulos I, et al. 1989. Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and ki-1-positive anaplastic large cell lymphoma: Dissociation between phenotype and genotype. Leuk Res 13:103-116.
171. Herling M, Rassidakis GZ, Medeiros J, et al. 2003. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: Associations with presenting features, serum interleukin 10 levels, and clinical outcome. Clin Cancer Res 9:2114-2120.
172. Hinz M, Lemke P, Anagnostopoulos I, et al. 2002. Nuclear factor κBdependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J Exp Med 196:605-617.
173. Hinz M, Löser P, Mathas S, Krappmann D, Dörken B, Scheidereit C. 2001. Constitutive NFκB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of anti-apoptotic genes in Hodgkin/Reed-Sternberg cells. Blood 97:2798-2807.
174. Hjalgrim H, Askling J, Pukkala E, Hansen S, Munksgaard L, Frisch M. 2001. Incidence of Hodgkin's disease in Nordic countries. Lancet 358:297-298.
175. Hjalgrim H, Askling J, Rostgaard K, et al. 2003. Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med 349:1324-1332.
176. Hjalgrim H, Askling J, Sorensen P, et al. 2000. Risk of Hodgkin's disease and other cancers after infectious mononucleosis. J Natl Cancer Inst 92:1522-1528.
177. Hjalgrim H, Rostgaard K, Askling J, et al. 2002. Hematopoietic and lymphatic cancers in relatives of patients with infectious mononucleosis. J Natl Cancer Inst 94:678-681.
178. Hodgkin T. 1832. On some morbid appearances of the absorbent glands and spleen. Med Chir Trans 17:68-114.
179. Horm JW, Asire AJ, Young JL, et al. 1985. SEER Program: Cancer Incidence and Mortality in the United States, 1973-1981. NIH publication no. 85-1837. Bethesda, MD: National Cancer Institute, US Department of Health and Human Services.
180. Hors J, Dausset J. 1983. HLA and susceptibility in Hodgkin's disease [review]. Immunol Rev 70:167-192.
181. Horwitz M, Wiernik PH. 1999. Pseudoautosomal linkage of Hodgkin disease. Am J Hum Genet 65:1413-1422.
182. Hoster HA, Dratman MV, Craver LF, Rolnick HA. 1948. Hodgkin's disease 1832-1947. Cancer Res 8:Part I 1-48; Part II 49-78.
183. Hsu SM, Zie SS, Hsu PL, Waldron JA Jr. 1992. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease. Am J Pathol 141:129-138.
184. Hu E, Hufford S, Lukes R, et al. 1988. Third-world Hodgkin's disease in Los Angeles County-University of Southern California Medical Center. J Clin Oncol 6:1285-1292.
185. Hudson MM, Poquette CA, Lee J, et al. 1998. Increased mortality after successful treatment for Hodgkin's disease. J Clin Oncol 16:3592-3600.
186. IARC. 1997. Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 70. Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France: International Agency for Research on Cancer, pp. 47-373.
187. Infante-Rivard C, Amre D, Gautrin D, Malo J-L. 2001. Family size, day-care attendance and breastfeeding in relation to the incidence of childhood asthma. Am J Epidemiol 153:653-658.
188. Isager H, Larsen S. 1980. Pre-morbid factors in Hodgkin's disease. III. School contact among patients. Scan J Haematol 25:158-164.
189. Izban KF, Ergin M, Huang Q, et al. 2001. Characterization of NF-kappaB expression in Hodgkin's disease: Inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells. Mod Pathol 14:297-310.
190. Izumi KM, Kieff ED. 1997. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NFκB. Proc Natl Acad Sci USA 94:12592-12597.
191. Jackson H Jr., Parker F Jr. 1944a. Hodgkin's disease I. General considerations. N Engl J Med 230:1-8.
192. Jackson H Jr., Parker F Jr. 1944b. Hodgkin's disease II. Pathology. N Engl J Med 231:35-44.
193. Jacquez GM. 1994a. Cuzick and Edwards' test when exact locations are unknown. Am J Epidemiol 140:58-64.
194. Jacquez GM. 1994b. STAT! Statistical software for the clustering of health events. Ann Arbor, MI: BioMedware.
195. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. 2001. Pathology & Genetics of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon, France: International Agency for Research on Cancer.
196. Jarrett RF, Armstrong AA, Alexander E. 1996. Epidemiology of EBV and Hodgkin's lymphoma. Ann Oncol 7:(Suppl 4):S5-S10.
197. Jarrett RF, Gallagher A, Jones DB, et al. 1991. Detection of Epstein-Barr virus genomes in Hodgkin's disease: Relation to age. J Clin Pathol 44:844-848.
198. Jarrett RF, Krajewski AS, Angus B, et al. 2003. The Scotland and Newcastle epidemiological study of Hodgkin's disease: Impact of histopathological review and EBV status on incidence estimates. J Clin Pathol 56:811-816.
199. Johnson SK, Johnson RE. 1972. Tonsillectomy history in Hodgkin's disease. N Engl J Med 287:1122-1125.
200. Jucker M, Abts H, Li W, et al. 1991. Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease. Blood 77:2413-2418.
201. Jungnickel B, Staratschek-Jox A, Bräuninger A, et al. 2000. Clonal deleterious mutations in the IκBα gene in the malignant cells in Hodgkin's lymphoma. J Exp Med 191:395-401.
202. Kadin ME, Liebowitz DN. 1999. Cytokines and cytokine receptors in Hodgkin's disease. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM, eds. Hodgkin's Disease. Philadelphia: Williams Wilkins, pp. 139-157.
203. Kahn KS, Tatham LM, Patel AV, Thun MJ, Heath Jr. CW. 1998. Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA 280:910-912.
204. Kaplan HS. 1980. Hodgkin's Disease, 2nd ed. Cambridge, MA: Harvard University Press.
205. Kapp U, Yeh WC, Patrerson B, et al. 1999. Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J Exp Med 189:1939-1946.
206. Kass AM. 1984. Doctors afield: Dr. Thomas Hodgkin's friendship with Sir Moses Montefiore. N Engl J Med 310:401-404.
207. Kass AM, Kass EH. 1988. Perfecting the World: The Life and Times of Dr. Thomas Hodgkin 1798-1866. New York: Harcourt Brace Javanovich.
208. Khan G, Coates PJ, Gupta RK, Kangro HO, Slavin G. 1992. Presence of Epstein-Barr virus in Hodgkin's disease is not exclusive to Reed-Sternberg cells. Am J Pathol 140:757-762.
209. Khan G, Norton AJ, Slavin G. 1993. Epstein-Barr virus in Hodgkin's disease: Relation to age and subtype. Cancer 71:3124-3129.
210. Kieff E, Liebowitz D. 1990. Epstein-Barr virus and its replication. In: Fields B, Knipe DM, eds. Virology. 2nd ed. New York: Raven Press, pp. 1889-1920.
211. Kirchoff LV, Evans AS, McClelland KE, Carvalho RP, Pannuti CS. 1980. A case-control study of Hodgkin's disease in Brazil. I. Epidemiologic aspects. Am J Epidemiol 112:595-608.
212. Kishimoto T, Akira S, Narazaki M, Taga T. 1995. Interleukin-6 family of cytokines and gp130. Blood 86:1243-1254.
213. Klein S, Jucker M, Diehl V, Tesch H. 1992. Production of multiple cytodines by Hodgkin's disease derived cell lines. Hematol Oncol 10:319-329.
214. Knecht H, Bachmann E, Brousset P, et al. 1993a. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 82:2037-2042.
215. Knecht H, Brousset P, Bachmann E, Sandvej K, Odermatt BF. 1993b. Latent membrane protein 1: A key oncogene in EBV-related carcinogenesis? Acta Haematol 90:167-171.
216. Knox G. 1963. Detection of low intensity epidemicity: Application to cleft lip and palate. Br J Prev Soc Med 17:121-127.
217. Kopp E, Ghosh S. 1994. Inhibition of NFκB by sodium salicylate and aspirin. Science 265:956-959.
218. Kramer U, Heinrich J, Wjst M, Wichmann HE. 1999. Age of entry to day nursery and allergy in later childhood. Lancet 353:450-454.
219. Kravdal O, Hansen S. 1993. Hodgkin's disease: The protective effect of childbearing. Int J Cancer 55:909-914.
220. Kryscio RJ, Myers MH, Prusiner ST, Heise HW, Christine BW. 1973. The space-time distribution of Hodgkin's disease in Connecticut, 1940-1969. J Natl Cancer Inst 50:1107-1110.
221. Kung FH. 1991. Hodgkin's disease in children four years of age or younger. Cancer 67:1428-1430.
222. Kuppers R. 2003. Somatic hypermutation and B cell receptor selection in normal and transformed human B cells. Ann NY Acad Sci 987:173-179.
223. Küppers R, Klein U, Hansmann M-L, Rajewsky K. 1999. Cellular origin of human B-cell lymphomas. N Engl J Med 341:1520-1529.
224. Kusuda M, Toriyama K, Kamidigo NO, Itakura H. 1998. A comparison of epidemiologic, histologic, and virologic studies on Hodgkin's disease in western Kenya and Nagasaki, Japan. Am J Trop Med Hyg 59:801-807.
225. Kusuhara K, Takabayashi A, Ueda K, et al. 1997. Breast milk is not a significant source for early Epstein-Barr virus or human herpesvirus 6 infection in infants; a seroepidemiologic study in two endemic areas of human T-cell lymphotropic virus type I in Japan. Microbiol Immunol 41:309-312.
226. Kusunoki Y, Kyoizumi S, Fukuda Y, et al. 1994. Immune responses to Epstein-Barr virus in atomic bomb survivors: Study of precursor frequency of cytotoxic lymphoctyes and titer levels of anti-Epstein-Barr virus-related antibodies. Radiat Res 138:127-132.
227. Kvale G, Hoiby EA, Pedersen E. 1979. Hodgkin's disease in patients with previous infectious mononucleosis. Int J Cancer 23:593-597.
228. LaVecchia C, Negri E, D'Aranzo B, Franceschi S. 1989. Occupation and lymphoid neoplasms. Br J Cancer 60:385-388.
229. Lehtinen T, Lumio J, Dillner J, et al. 1993. Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies-a prospective study. Cancer Causes Control 4:187-193.
230. Levi F, Randimbison L, LaVecchia C, Erler G, Te V-C. 1997. Incidence of invasive cancers following squamous cell skin cancer. Am J Epidemiol 146:734-739.
231. Levine PH, Ebbesen P, Ablashi DV, Saxinger WC, Nordentoft A, Connelly RR. 1992. Antibodies to human herpes virus-6 and clinical course in patients with Hodgkin's disease. Int J Cancer 51:53-57.
232. Levine P, Pallesen G, Ebbesen P, Harris N, Evans AS, Mueller N. 1994. Evaluation of Epstein-Barr virus antibody patterns and detection of viral markers in the biopsies of patients with Hodgkin's disease. Int J Cancer 59:48-50.
233. Levine R, Zhu K, Gu Y, et al. 1998. Self-reported infectious mononucleosis and 6 cancers: A population-based, case-control study. Scand J Infect Dis 30:211-214.
234. Libetta CM, Pringle JH, Angel CA, Craft AW, Malcolm AJ, Lauder I. 1990. Demonstration of Epstein-Barr viral DNA informalin-fixed paraffin-embedded samples Hodgkin's disease. J Pathol 161:255-260.
235. Lichtenstein P, Holm NV, Verkasalo PK, et al. 2000. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark and Finland. N Engl J Med 343:78-85.
236. Lin AY, Kingma DW, Lennette ET, et al. 1996. Epstein-Barr virus and familial Hodgkin's disease. Blood 88:3160-3165.
237. Lin J-C, Lin S-C, De BK, Chan W-P, Evatt BL. 1993. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): Predominance of type A virus associated with Hodgkin's disease. Blood 81:3372-3381.
238. Linet MS, Pottern LM. 1992. Familial aggregation of hematopoietic malignancies and risk of non-Hodgkin's lymphoma. Cancer Res 52(19 Suppl): 5458s-5473s.
239. Lukes RJ, Butler JJ. 1966. The pathology and nomenclature of Hodgkin's disease. Cancer Res 26:1063-1081.
240. Lukes RJ, Tindle BH, Parker JW. 1969. Reed-Sternberg-like cells in infectious mononucleosis. Lancet 2:1003-1004.
241. Lynch HT. 2000. Anticipation in familial Hodgkin's lymphoma. Hum Genet 107:290-293.
242. Lynch HT, Marcus JN, Lynch JF. 1992. Genetics of Hodgkin's and non-Hodgkin's lymphoma: A review. Cancer Investigation 10:247-256.
243. MacFarlane GJ, Evstifeeva TV, Boyle P, Grufferman S. 1995. International patterns in the occurrence of Hodgkin's disease in children and young adult males. Int J Cancer 61:165-167.
244. Mack TM, Cozen W, Shibata DK, et al. 1995. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med 332:413-418.
245. MacMahon B. 1957. Epidemiological evidence on the nature of Hodgkin's disease. Cancer 10:1045-1054.
246. MacMahon B. 1966. Epidemiology of Hodgkin's disease. Cancer Res 26:1189-1201.
247. Mantel N. 1967. The detection of disease clustering and a generalized regression approach. Cancer Res 27:209-220.
248. Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J. Investigators of the Club Rhumatismes et Inflammation. 2002. Lymphomas in rheumatoid arthritis patients treated with methotrexate: A three-year prospective study in France. Blood 99:3909-3915.
249. Marshall NA, Christie LE, Munro LR, et al. 2004. Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin's lymphoma. Blood 103:1755-1762.
250. Martinez-Maza O, Breen EC. 2002. B-cell activation and lymphoma in patients with HIV. Curr Opin Oncol 14:528-532.
251. Masih A, Weisenburger D, Duggan M, et al. 1991. Epstein-Barr viral genome in lymph nodes from patients with Hodgkin's disease may not be specific to Reed-Sternberg cells. Am J Pathol 139:37-43.
252. Matricardi PM, Yazdanbakhsh M. 2003. Mycobacteria and atopy, 6 years later: A fascinating, still unfinished, business. Clin Exp Allergy 33:717-720.
253. McCunney RJ. 1999. Hodgkin's disease, work and the environment: A review. J Occup Environ Med 41:36-46.
254. Melnick JL. 1997. Poliovirus and other enteroviruses. In: Evans AS, Kaslow RA, eds. Viral Infections of Humans: Epidemiology and Control. 4th ed. New York: Plenum, p. 609.
255. Mertens AC, Yasui Y, Neglia JP, et al. 2001. Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivor Study. J Clin Oncol 19:3163-3172.
256. Merz H, Fleidner A, Orscheschek K, et al. 1991. Cytokine expression in T-cell lymphomas and Hodgkin's disease: Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth. Am J Pathol 139:1173-1180.
257. Milham S Jr., Hesser JE. 1967. Hodgkin's disease in woodworkers. Lancet 2:136-137.
258. Milham S Jr. 1974. Mortality experience of the AFL-CIO United Brotherhood of Carpenters and Joiners of America, 1969-1970. DHEW publication no. (NIOSH) 174-129. Cinncinnati, Ohio, Office of Technical Publications.
259. Miller BA, Kolonel LN, Bernstein L, et al. 1996. Racial/ethnic patterns of cancer in the United States 1988-1992. NIH publication no. 96-4104. Bethesda, MD: National Cancer Institute.
260. Miller RW, Beebe GW. 1973. Infectious mononucleosis and the empirical risk of cancer. J Natl Cancer Inst 50:315-321.
261. Moore KW, De Waal Malelyt R, Coffman RRL, O' Garra A. 2001. Interleukin 10 and the interleukin-10 receptor. Ann Rev Immunol 19:683-765.
262. Mueller NE. 1987. The epidemiology of Hodgkin's disease. In: Selby D, McElwain TJ, eds. Hodgkin's Disease. London: Blackwell Scientific Publications, pp. 68-93.
263. Mueller NE. 1996. Hodgkin's disease. In: Schottenfeld D, Fraumenti JF Jr, eds. Cancer Epidemiology and Prevention, 2nd ed. New York: Oxford University Press, pp. 893-919.
264. Mueller NE. 1997. Epstein-Barr virus and Hodgkin's disease: An epidemiological paradox. EBV Report 4:1-2.
265. Mueller NE. 1999. Overview of the epidemiology of malignancy in immune deficiency. J Acquir Immune Defic Syndr 21(Suppl):S5-10.
266. Mueller N, Evans A, Harris NL, et al. 1989. Hodgkin's disease and Epstein-Barr virus. Altered antibody Pattern before diagnosis. N Engl J Med 320:689-695.
267. Mueller NE, Grufferman S. 1999. The epidemiology of Hodgkin's disease. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM, eds. Hodgkin's Disease. Philadelphia: Lippincott Williams and Wilkins, pp. 61-77.
268. Mueller N, Swanson GM, Hsieh C-C, Cole P. 1987. Tonsillectomy and Hodgkin's disease: Results from companion population-based studies. J Natl Cancer Inst 78:1-5.
269. Munoz N, Davidson RJL, Witthoff B, Ericsson JE, De-The G. 1978. Infectious mononucleosis and Hodgkin's disease. Int J Cancer 22:10-13.
270. Murray PG, Young LS, Rowe M, Crocker J. 1992. Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease. J Pathol 166:1-5.
271. Neglia JP, Friedman DL, Yasui Y, et al. 2001. Second malignant neoplasms in five-year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst 93:618-629.
272. Negri E, La Vecchia C, Franceschi S, D'Avanzo B, Parazzini F. 1991. Vegetable and fruit consumption and cancer risk. Int J Cancer 48:350-354.
273. Newell GR. 1970. Etiology of multiple sclerosis and Hodgkin's disease. Am J Epidemiol 91:119-122.
274. Ng AK, Bernard MV, Weller E, et al. 2002. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors. Blood 100:1989-1996.
275. Niedobitek G, Herbst H, Young LS, et al. 1992. Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood 79:2520-2526.
276. Niedobitek G, Kremmer E, Herbst H, et al. 1997. Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane 2A in Hodgkin's disease and infectious mononucleosis. Blood 90:1664-1672.
277. Niedobitek G, Rowlands DC, Young LS, et al. 1993. Overexpression of p53 in Hodgkin's disease: Lack of correlation with Epstein-Barr virus infection. J Pathol 169:207-212.
278. Ohshima K, Akaiwa M, Umeshita R, Suzumiya J, Izuhara K, Kikuchi M. 2001. Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: Possible autocrine mechanism and involvement in fibrosis. Histopathology 38:368-375.
279. Ohshima K, Kikuchi M, Eguchi F, et al. 1990. Analysis of Epstein-Barr viral genomes in lymphoid malignancy using southern blotting, polymerase chain reaction and in situ hybridization. Virchows Arch B Cell Pathol Incl Mol Pathol 59:383-390.
280. Ohshima K, Suzumiya J, Akamatu M, Takeshita M, Kikuchi M. 1995. Human and viral interleukin-10 in Hodgkin's disease, and its influence on CD4+ and CD8+ T lymphocytes. Int J Cancer 62:5-10.
281. Olsen JH, Boice JD, Seersholm N, Bautz A, Fraumeni JF Jr. 1995. Cancer in the parents of children with cancer. N Engl J Med 333:1594-1599.
282. Olsen J, Sabroe S. 1979. A follow-up study of non-retired and retired members of the Danish Carpenters/Cabinet Marker's Trade Union. Int J Epidemiol 8:375-382.
283. Oshima Y, Puri PK. 2001. Suppression of an IL-13 autocrine growth loop in a human Hodgkin/Reed-Sternberg tumor cell line by a novel IL-13 antagonist. Cell Immunol 211:37-42.
284. Oudejans JJ, van den Brule AJC, Jiwa NM, et al. 1995. BHRFl, the Epstein-Barr virus (EBV) homologue of the BCL-2 proto-oncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes. Blood 86:1883-1902.
285. Oza AM, Tonks S, Lim J, Fleetwood MA, Lister TA, Dodmer JG and Collaborating Centers. 1994. A clinical epidemiological study of human leukocyte antigen-DPB alleles in Hodgkin's disease. Cancer Res 54:5101-5105.
286. Paffenbarger RS Jr., Wilson VO. 1955. Previous tonsillectomy and current pregnancy as they affect risk of poliomyelitis attack. Ann NY Acad Sci 61:856-868.
287. Paffenbarger RS Jr., Wing AL, Hyde RT. 1977. Characteristics in youth indicative of adult onset Hodgkin's disease. J Natl Cancer Inst 58:1489-1491.
288. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS. 1991a. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337:320-322.
289. Pallesen G, Sandvej K, Hamilton-Dutoit SJ, Rowe M, Young LS. 1991b. Activation of Epstein-Barr virus replication in Hodgkin and Reed-Sternberg cells. Blood 78:1162-1165.
290. Palli D, Trallori G, Bagnoli S, et al. 2000. Hodgkin's disease risk is increased in patients with ulcerative colitis. Gastroenterology 119:647-653.
291. Paltiel O, Schmit T, Adler B, et al. 2000. The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma. Results and limitations of a registry-linked study. Cancer 88:2357-2366.
292. Parkin DM, Ferlay J, Hamdi-Cherif M, et al., eds. 2002a. Cancer in Africa: Epidemiology and Prevention. IARC Scientific Publication No. 153. Lyon, France: International Agency for Research on Cancer.
293. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, eds. 1992. Cancer Incidence in Five Continents, Vol VI. IARC Scientific Publication No. 120. Lyon, France: International Agency for Research on Cancer.
294. Parkin DM, Stiller CA, Draper GJ, Bieber CA. 1988. The international incidence of childhood cancer. Int J Cancer 41:511-520.
295. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas D, eds. 2002b. Cancer Incidence in Five Continents. Vol VIII. IARC Scientific Publication No. 155. Lyon, France: International Agency for Research on Cancer.
296. Petersen GR, Milham S Jr. 1974. Hodgkin's disease mortality and occupational exposure to wood. J Natl Cancer Inst 53:957-958.
297. Pike MC, Henderson BE, Casagrande J, et al. 1974. Infectious aspects of Hodgkin's disease. [letter] N Engl J Med 290:341.
298. Poppema S. 2005. Immunobiology and pathophysiology of Hodgkin lymphoma. Hematology (Am Soc Hematol Educ Program) p. 239-244.
299. Poppema S, Visser L. 1994. Epstein-Barr virus positivity in Hodgkin's disease does not correlate with an HLA A2-negative phenotype. Cancer 73:3059-3063.
300. Portis T, Dyck P, Longnecker R. 2003. Epstein-Barr (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells in Hodgkin lymphoma. Blood 102:4166-4178.
301. Poskanzer DC. 1965. Tonsillectomy and multiple sclerosis. Lancet ii:1264-1266.
302. Preciado MV, De Matteo E, Diez B, Menárguez J, Grinstein S. 1995. Presence of Epstein-Barr virus and strain type assignment in Argentine childhood Hodgkin's disease. Blood 86:3922-3929.
303. Razis DV, Diamond HD, Craver LF. 1959. Familial Hodgkin's disease: Its significance and implications. Ann Intern Med 51:933-971.
304. Razzouk BI, Gan YJ, Mendonça C, et al. 1997. Epstein-Barr virus in pediatric Hodgkin disease: Age and histiotype are more predictive than geographic region. Med Peiatr Oncol 28:248-254.
305. Reed DM. 1902. On the pathological changes in Hodgkin's disease with especial reference to its relation to tuberculosis. Johns Hopkins Hospital Report 10:133-196.
306. Rickinson AB, Kieff E. 1996. Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM, et al., eds. Fields Virology. Vol 2, 3rd ed. Philadelphia: Lippincott-Raven Publishers, pp. 2397-2446.
307. Ries LAG, Eisner MP, Kosary CL, et al., eds. 2002. SEER Cancer Statistics Review: 1973-1999. National Cancer Institute, Bethesda, MD. Available at: 1999/.
308. Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK, eds. 1997. SEER Cancer Statistics Review: 1973-1994. NIH publication no. 97-2789. National Cancer Institute, Bethesda, MD.
309. Rosdahl N, Larsen SO, Clemmesen J. 1974. Hodgkin's disease in patients with previous infectious mononucleosis: 30 years' experience. Br Med J 2:253-256.
310. Rosenfeld L. 1993. Thomas Hodgkin: Morbid Anatomist and Social Activist. Lanham, MD, Madison.
311. Rowlings PA, Curtis RE, Passweg Jr. et al. 1999. Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation. J Clin Oncol 17:3122-3127.
312. Rubertone MV, Brundage JF. 2002. The defense medical surveillance system and the Department of Defense Serum Repository: Glimpses of the future of comprehensive public health surveillance. Am J Public Health 92:1900-1904.
313. Samoszuk M, Nansen L. 1990. Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 75:13-16.
314. Samoszuk M, Ramzi E. 1993. IgE, Reed-Sternberg cells, and eosinophilia in Hodgkin's disease. Leuk Lymphoma 9:315-319.
315. Sanderson CJ. 1992. Interleukin-5, eosinophils, and disease. Blood 79:3101-3109.
316. Sankila R, Garwicz S, Olsen JH, et al. 1996. Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five Nordic countries. J Clin Oncol 14:1442-1446.
317. Scherr P, Gutensohn (Mueller) N, Cole P. 1984. School contact among persons with Hodgkin's disease. Am J Epidemiol 120:29-38.
318. Schimpff SC, Brager DM, Schimpff CR, Comstock GW, Wiernik PH. 1976. Leukemia and lymphoma patients linked by prior social contact. Evaluation using a case-control approach. Ann Intern Med 84:547-550.
319. Schlaifer D, Rigal-Huguet F, Robert A, et al. 1994. Epstein-Barr virus in familial Hodgkin's disease. Br J Haematol 88:636-638.
320. Schlegel RJ, Bellanti JA. 1969. Increased susceptibility of males to infection. Lancet 2:826-827.
321. Schmidt CA, Oettle H, Peng R, et al. 2000. Presence of human β-and γ-herpes virus DNA in Hodgkin's disease. Leuk Res 24:865-870.
322. Schwaller J, Tobler A, Niklaus G, et al. 1995. Interleukin-12 expression in human lymphomas and non-neoplastic lymphoid disorders. Blood 85:2182-2188.
323. Schwartzbaum JA, George SL, Pratt CB, David B. 1991. An exploratory study of environmental medical factors potentially related to childhood cancer. Med Pediatr Oncol 19:115-121.
324. Serraino D, Franceschi S, Talamini R, et al. 1991. Socio-economic indicators, infectious diseases and Hodgkin's disease. Int J Cancer 47:352-357.
325. Shiramizu B, Chang CW, Cairo MS. 2001. Absence of human herpes-6 genome by polymerase chain reaction in children with Hodgkin disease: A Children's Cancer Group Lymphoma Biology Study. J Pediatr Hematol/Oncol 23:282-285.
326. Shpilberg O, Modan M, Modan B, Chetrit A, Fuchs Z, Ramot B. 1994. Familial aggregation of haematological neoplasms: A controlled study. Br J Haematol 87:75-80.
327. Shugart YY. 1998. Anticipation in familial Hodgkin lymphoma. Am J Hum Genet 63:270-272.
328. Shugart YY, Hemminki K, Vaittinen P, Kingman A, Dong C. 2000. A genetic study of Hodgkin's lymphoma: An estimate of heritability and anticipation based on the familial cancer database in Sweden. Hum Genet 106:553-556.
329. Siebert R, Louie D, Lacher M, Schlager A, Offit K. 1997. Familial Hodgkin's and non-Hodgkin's lymphoma: Different patterns in first-degree relatives. Leuk Lymphoma 27:503-507.
330. Simpson CR, Anderson WJA, Helms PJ, et al. 2002. Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized General Practice data. Clin Exp All 32:37-42.
331. Skinnider BF, Elia AJ, Gascoyne RD, et al. 2001. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin's lymphoma. Blood 97:250-255.
332. Skinnider BF, Elia AJ, Gascoyne RD, et al. 2002a. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin's lymphoma. Blood 99:618-626.
333. Skinnider BF, Kapp U, Mak TW. 2002b. The role of interleukin-13 in classical Hodgkin's lymphoma. Leuk Lymphoma 43:1203-1210.
334. Skinnider BF, Mak TW. 2002. The role of cytokines in classical Hodgkin's lymphoma. Blood 99:4283-4297.
335. Sleckman B, Mauch PM, Ambinder RF, et al. 1998. Epstein-Barr virus in Hodgkin's disease: Correlation of risk factors and disease characteristics with molecular evidence of viral infection. Cancer Epidemiol Biomarkers Prev 7:1117-1121.
336. Smedby KE, Hjalgrim H, Melbye M, et al. 2005. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 97:199-209.
337. Smith PG, Pike MC. 1974. Case clustering in Hodgkin's disease: A brief review of the present position and report of current work in Oxford. Cancer Res 34:1156-1160.
338. Smith PG, Pike MC, Kinlen LJ, Jones A, Harris R. 1977. Contacts between young patients with Hodgkin's disease. A case-control study. Lancet 2:59-62.
339. Spieker T, Kurth J, Küppers R, Rajewsky K, Bräuninger A, Hansmann M-L. 2000. Molecular single-cell analysis of the clonal relationship of small Epstein-Barr virus-infected cells and Epstein-Barr virus-harboring Hodgkin and Reed-Sternberg cells in Hodgkin's disease. Blood 96:3133-3138.
340. Spitz MR, Sider JG, Johnson CC, Butler JJ, Pollack ES, Newell GR. 1986. Ethnic patterns of Hodgkin's disease incidence among children and adolescents in the United States, 1973-1982. J Natl Cancer Inst 76:235-239.
341. Staal SP, Ambinder R, Beschorner WE, Hayward GS, Mann R. 1989. A survey of Epstein-Barr virus DNA in lymphoid tissue: Frequent detection in Hodgkin's disease. Am J Clin Pathol 91:1-5.
342. Stein H, Diehl V, Marafioti T, Jox A, Wolf J, Hummel M. 1999. The nature of Reed-Sternberg cells, lymphocytic and histiocytic cells. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM, eds. Hodgkin's Disease. Philadelphia: Lippincott Williams and Wilkins, pp. 121-138.
343. Sternberg C. 1898. Uber eine eigenartige unter dem Bilde der Pseudoleukamie verlaufende Tuberculose des lymphatischen apparates. Zeitschrift fur Heilkunde 19:21-91.
344. Strachan DP, Taylor EM, Carpenter RG. 1996. Family structure, neonatal infection, and hay fever in adolescence. Arch Dis Child 74:422-426.
345. Straus SE, Jaffe ES, Puck JM, et al. 2001. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 98:194-200.
346. Sultan SM, Ioannou Y, Isenberg DA. 2000. Is there an association of malignancy with systemic lupus erythematosis? An analysis of 276 patients under long-term review. Rheumatology 39:1147-1152.
347. Tavani A, La Vecchia C, Gallus S, et al. 2000. Red meat intake and cancer risk: A study in Italy. Int J Cancer 86:425-428.
348. Tavani A, Pregnolato A, Negri E, et al. 1997. Diet and risk of lymphoid neoplasms and soft tissue sarcomas. Nutr Cancer 27:256-260.
349. Travis LB, Hill DA, Dores GM, et al. 2003. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 290:465-475.
350. Uhara H, Sato Y, Mukai K, et al. 1990. Detection of Epstein-Barr virus DNA in Reed-Sternberg cells of Hodgkin's disease using the polymerase chain reaction and in situ hybridization. Jpn J Cancer Res 81:272-278.
351. Van Der Ouderaa FJ, Buytenhek M, Nugteren DH, Van Dorp DA. 1980. Acetylation of prostaglandin endoperoxide synthetase with acetylsalicylic acid. Eur J Biochem 109:1-8.
352. Vasef MA, Kamel OW, Chen Y-Y, Medeiros LJ, Weiss LM. 1995. Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease. Am J Pathol 147:1408-1415.
353. Veltri RW, Shan SH, McClung JE, Klingberg WD, Sprinkle PM. 1983. Epstein-Barr virus, fatal infectious mononucleosis, and Hodgkin's disease in siblings. Cancer 51:509-520.
354. Vianna NJ, Greenwald P, Davies JN. 1971. Extended epidemic of Hodgkin's disease in high school students. Lancet 1:1209-1211.
355. Vianna NJ, Greenwald P, Polan A, Koeogh MD, Davies JNP. 1974. Tonsillectomy and Hodgkin's disease. Lancet ii:168-169.
356. Vianna NJ, Polan AK. 1973. Epidemiologic evidence for transmission of Hodgkin's disease. N Engl J Med 289:499-502.
357. Vineis P, Crosignaru P, Sacerdote C, et al. 2000. Hematopoietic cancer and medical history: A multicentre case control study. J Epidemiol Community Health 54:431-436.
358. Von Mutius E, Martinez FD, Fritzsch C, Nicolai T, Reitmeir P, Thiemann H-H. 1994. Skin test-reactivity and number of siblings. Br Med J 308:692-695.
359. Von Mutius E, Weiland SK, Fritzsch C, Duhme H, Keil U. 1998. Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany. Lancet 351:862-866.
360. Washburn TC, Medearis DN, Childs B. 1965. Sex differences in susceptibility to infections. Pediatrics 35:57-64.
361. Weinreb M, Day PJR, Niggli F, et al. 1996. The role of Epstein-Barr virus in Hodgkin's disease from different geographical area. Arch Dis Child 74:27-31.
362. Weiss LM, Chan JKC, MacLennan K, Warnke RA. 1999. Pathology of classical Hodgkin's disease. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM, eds. Hodgkin's Disease. Philadelphia: Lippincott Williams and Wilkins, pp. 101-120.
363. Weiss LM, Chen Y-Y, Liu X-F, Shibata D. 1991. Epstein-Barr virus and Hodgkin's disease: A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 139:1259-1265.
364. Weiss LM, Strickler JG, Warnke RA, Purtilo DT, Sklar J. 1987. Epstein-Barr virus DNA in tissues of Hodgkin's disease. Am J Pathol 129:86-91.
365. Westergaard T, Melbye M, Pedersen JB, Frisch M, Olsen JH, Andersen PK. 1997. Birth order, sibship size and risk of Hodgkin's disease in children and young adults: A population-based study of 31 million person-years. Int J Cancer 72:977-981.
366. White L, McCourt BA, Isaacs H, Siegel SE, Stowe SM, Higgins GR. 1983. Patterns of Hodgkin's disease at diagnosis in young children. Am J Pediatr Hematol Oncol 5:251-257.
367. Wiernik PH, Ashwin M, Hu XP, Paietta E, Brown K. 2001. Anticipation in familial chronic lymphocytic leukemia. Br J Haematol 113:407-414.
368. Wiernik PH, Wang SQ, Hu XP, Marino P, Paietta E. 2000. Age of onset evidence for anticipation in familial non-Hodgkin's lymphoma. Br J Haematol 108:72-79.
369. Wilkinson JD, Fleming LE, MacKinnon J, et al. 2001. Lymphoma and lymphoid leukemia incidence in Florida children: Ethnic and racial distribution. Cancer 91:1402-1408.
370. Wolf J, Kapp U, Bohlen H, et al. 1996. Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed-Sternberg cells. Blood 87:3418-3428.
371. Wolk A, Gridley G, Svensson M, et al. 2001. A prospective study of obesity and cancer risk. Cancer Causes Control 12:13-21.
372. Yang P, Grufferman S, Schwartz AG, et al. 1993. A genetic analysis of Hodgkin's disease. Am J Hum Genet 53:A391.
373. Yates JL, Bunting CH. 1915. The rational treatment of Hodgkin's disease. JAMA 64:1953-1961.
374. Yin MJ, Yamamoto Y, Gaynor RB. 1998. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IkB kinase-b. Nature 396:77-80.
375. Young LS. 1994. Ludwig/CRC EBV Meeting. EBV Report 1:10-12.
376. Zack MM Jr, Heath CW Jr., Andrews MD, Grivas AS Jr., Christine B W. 1977. High school contact among persons with leukemia and lymphoma. J Natl Cancer Inst 59:1343-1349.
377. Zhou XG, Sandvej K, Li PJ, et al. 2001. Epstein-Barr virus (EBV) in Chinese pediatric Hodgkin's disease: Hodgkin's disease in young children is an EBV-related lymphoma. Cancer 92:1621-1631.
378. Zwitter M, Zakelj MP, Kosmelj K. 1996. A case-control study of Hodgkin's disease and pregnancy. Br J Cancer 73:246-251.